These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 26443352)

  • 1. Vaccines against Infections Caused by Salmonella, Shigella, and Pathogenic Escherichia coli.
    Guzman CA; Borsutzky S; Favre D; Dietrich G
    EcoSal Plus; 2004 Dec; 1(1):. PubMed ID: 26443352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of the current status of enteric vaccines.
    Levine MM; Noriega F
    P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacterial enteric infections and vaccine development.
    Holmgren J; Svennerholm AM
    Gastroenterol Clin North Am; 1992 Jun; 21(2):283-302. PubMed ID: 1512046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Live oral typhoid vaccine Salmonella Typhi Ty21a - a surrogate vaccine against non-typhoid salmonella?
    Kantele A; Pakkanen SH; Siitonen A; Karttunen R; Kantele JM
    Vaccine; 2012 Nov; 30(50):7238-45. PubMed ID: 23084770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Vaccination against the enterobacteria responsible for enteric infections].
    Sansonetti PJ
    Ann Gastroenterol Hepatol (Paris); 1994; 30(2):60-3. PubMed ID: 8210205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First multi-epitope subunit vaccine against extraintestinal pathogenic Escherichia coli delivered by a bacterial type-3 secretion system (T3SS).
    Wieser A; Magistro G; Nörenberg D; Hoffmann C; Schubert S
    Int J Med Microbiol; 2012 Jan; 302(1):10-8. PubMed ID: 22000741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Future vaccines against enteric pathogens.
    Levine MM; Edelman R
    Infect Dis Clin North Am; 1990 Mar; 4(1):105-21. PubMed ID: 2155260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Vaccination against the enterobacteriaceae responsible for enteric infections].
    Sansonetti PJ
    Bull Acad Natl Med; 1993 Nov; 177(8):1401-7; discussion 1407-8. PubMed ID: 8193944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The current status of diarrhoea related vaccines.
    Sarkar SK; Pal SC
    Indian J Public Health; 1990; 34(1):20-34. PubMed ID: 1966245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stable expression of Shigella sonnei form I O-polysaccharide genes recombineered into the chromosome of live Salmonella oral vaccine vector Ty21a.
    Dharmasena MN; Hanisch BW; Wai TT; Kopecko DJ
    Int J Med Microbiol; 2013 Apr; 303(3):105-13. PubMed ID: 23474241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-reactive immune response elicited by parenteral Vi polysaccharide typhoid vaccine against non-typhoid Salmonellae.
    Pakkanen SH; Kantele JM; Herzog C; Kantele A
    Vaccine; 2014 Jan; 32(5):544-51. PubMed ID: 24342246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination of attenuated EIS-producing Salmonella induces protective immunity against enterohemorrhagic Escherichia coli in mice.
    Gu J; Ning Y; Wang H; Xiao D; Tang B; Luo P; Cheng Y; Jiang M; Li N; Zou Q; Mao X
    Vaccine; 2011 Oct; 29(43):7395-403. PubMed ID: 21807051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a tripartite vector system for live oral immunization using a gram-negative probiotic carrier.
    Buddenborg C; Daudel D; Liebrecht S; Greune L; Humberg V; Schmidt MA
    Int J Med Microbiol; 2008 Jan; 298(1-2):105-14. PubMed ID: 17936683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral vaccination against enteric bacterial infections: an overview.
    Germanier R
    Behring Inst Mitt; 1984 Nov; (76):98-105. PubMed ID: 6395852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [An oral enteritis-vaccine composed of twelve heat inactivated Enterobacteriaceae. 1. Communication: Theoretical and epidemiological considerations (author's transl)].
    Raettig H
    Zentralbl Bakteriol Orig A; 1979; 245(3):287-300. PubMed ID: 44783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis and genetic manipulation of Shigella virulence determinants for vaccine development.
    Mills SD; Sekizaki T; Gonzalez-Carrero MI; Timmis KN
    Vaccine; 1988 Apr; 6(2):116-22. PubMed ID: 3291449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined vaccine regimen based on parenteral priming with a DNA vaccine and administration of an oral booster consisting of a recombinant Salmonella enterica serovar Typhimurium vaccine strain for immunization against infection with human-derived enterotoxigenic Escherichia coli strains.
    Lásaro MO; Luiz WB; Sbrogio-Almeida ME; Nishimura LS; Guth BE; Ferreira LC
    Infect Immun; 2004 Nov; 72(11):6480-91. PubMed ID: 15501779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination against typhoid fever: present status.
    Ivanoff B; Levine MM; Lambert PH
    Bull World Health Organ; 1994; 72(6):957-71. PubMed ID: 7867143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prime-boost vaccine regimen confers protective immunity to human-derived enterotoxigenic Escherichia coli.
    Lasaro MO; Luiz WB; Sbrogio-Almeida ME; Ferreira LC
    Vaccine; 2005 Mar; 23(19):2430-8. PubMed ID: 15752829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-reactive immune response induced by the Vi capsular polysaccharide typhoid vaccine against Salmonella Paratyphi strains.
    Pakkanen SH; Kantele JM; Kantele A
    Scand J Immunol; 2014 Mar; 79(3):222-9. PubMed ID: 24383914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.